Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Peter R. Moosmann"'
Publikováno v:
Leukemia & Lymphoma. 51:149-152
Bendamustine was designed as a bifunctional anticancer compound combining an alkylating and an antimetabolite function. It shows unique mechanisms of action and incomplete cross resistance to other...
Publikováno v:
Blood. 112:1574-1574
Besides its established role in the treatment of patients with multiple myeloma, the proteasome inhibitor bortezomib is active in patients with a variety of indolent non-Hodgkin’s lymphomas, notably mantle cell lymphoma and follicular lymphoma. Ben
Autor:
Antje Schulze, Cornelia Becker, Rita Pasold, Ulrich Wedding, Astrid Franke, Dietger Niederwieser, Peter R. Moosmann, Rainer Krahl, Norma Peter, L Uharek
Publikováno v:
Blood. 104:870-870
Objectives: Hematopoietic growth factors are essential in accelerating myeloid reconstitution and reducing treatment morbidity of hematological and non-hematological malignant diseases. In order to understand in more detail the effect of G-CSF on mye